Rat Anti-BMP1 Recombinant Antibody (CBYY-0654) (CBMAB-0657-YY)

Name: Rat Anti-BMP1 Recombinant Antibody (CBYY-0654)
SKU: CBMAB-0657-YY
Rating: 5 (1 reviews)

See all BMP1 antibodies

Compare Online Inquiry

Datasheet

SDS

Request for COA

Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal

Rat

Clone

CBYY-0654

Application

WB, IP

Immunogen

Mouse myeloma cell line NS0-derived recombinant human BMP‑1/PCP Ala121-Gln730.

Host Species

Rat

Specificity

Human

Antibody Isotype

IgG2b

Clonality

Monoclonal

Application Notes

The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Application	Note
WB	2 µg/ml
IP	25 µg/ml

Formulations & Storage [For reference only, actual COA shall prevail!]

Format

Lyophilized

Buffer

PBS, Trehalose

Preservative

None

Storage

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

More Infomation

Target

Full Name

Bone Morphogenetic Protein 1

Introduction

This gene encodes a protein that is capable of inducing formation of cartilage in vivo. Although other bone morphogenetic proteins are members of the TGF-beta superfamily, this gene encodes a protein that is not closely related to other known growth factors. This gene is expressed as alternatively spliced variants that share an N-terminal protease domain but differ in their C-terminal region. [provided by RefSeq, Aug 2008]

Entrez Gene ID

649

UniProt ID

P13497

Alternative Names

Bone Morphogenetic Protein 1; Procollagen C-Endopeptidase; Mammalian Tolloid Protein; EC 3.4.24.19; PCOLC; PCP; Procollagen C-Proteinase 3; Procollagen C-Proteinase;

Function

Metalloprotease that plays key roles in regulating the formation of the extracellular matrix (ECM) via processing of various precursor proteins into mature functional enzymes or structural proteins (PubMed:33206546).
Thereby participates in several developmental and physiological processes such as cartilage and bone formation, muscle growth and homeostasis, wound healing and tissue repair (PubMed:33169406, PubMed:32636307).
Roles in ECM formation include cleavage of the C-terminal propeptides from procollagens such as procollagen I, II and III or the proteolytic activation of the enzyme lysyl oxidase LOX, necessary to formation of covalent cross-links in collagen and elastic fibers (PubMed:31152061, PubMed:33206546).
Additional substrates include matricellular thrombospondin-1/THBS1 whose cleavage leads to cell adhesion disruption and TGF-beta activation (PubMed:32636307).
Isoform BMP1-3: Plays an important role in bone repair by acting as a coactivator of BMP7.

Biological Process

Cartilage condensation Source: ProtInc
Cell differentiation Source: UniProtKB-KW
Collagen fibril organization Source: Reactome
Extracellular matrix disassembly Source: Reactome
High-density lipoprotein particle assembly Source: Reactome
Multicellular organism development Source: ProtInc
Ossification Source: UniProtKB-KW
Positive regulation of cartilage development Source: MGI
Proteolysis Source: UniProtKB
Skeletal system development Source: ProtInc

Cellular Location

Trans-Golgi network; Extracellular matrix; Secreted. Co-localizes with POSTN in the Golgi.
Isoform BMP1-3: Secreted

Involvement in disease

Osteogenesis imperfecta 13 (OI13): An autosomal recessive form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI13 is characterized by normal teeth, faint blue sclerae, severe growth deficiency, borderline osteoporosis, severe bone deformity, and recurrent fractures affecting both upper and lower limbs.

PTM

Proteolytically activated in the trans-Golgi network by furin-like/paired basic proprotein convertases, cleavage is not required for secretion.

Rafi, J. H., Jafar, T., Pathan, M. T., Reza, R., Islam, S., Sourna, I. J., ... & Ahammad, F. (2021). High expression of bone morphogenetic protein 1 (BMP1) is associated with a poor survival rate in human gastric cancer, a dataset approaches. Genomics, 113(1), 1141-1154.

Wang, J., Xie, X., Muench, N. A., Massoudi, D., Xu, C., Greenspan, D. S., & Feng, J. Q. (2021). Proteinase bone morphogenetic protein 1, but not tolloid‐like 1, plays a dominant role in maintaining periodontal homeostasis. Journal of Periodontology, 92(7), 1018-1029.

Strøm, T. B., Bjune, K., & Leren, T. P. (2020). Bone morphogenetic protein 1 cleaves the linker region between ligand-binding repeats 4 and 5 of the LDL receptor and makes the LDL receptor non-functional. Human molecular genetics, 29(8), 1229-1238.

Eshed-Eisenbach, Y., Devaux, J., Vainshtein, A., Golani, O., Lee, S. J., Feinberg, K., ... & Peles, E. (2020). Precise spatiotemporal control of nodal Na+ channel clustering by bone morphogenetic protein-1/Tolloid-like proteinases. Neuron, 106(5), 806-815.

Su, Z., He, L., Shang, H., Dai, T., Xu, F., & Zhao, J. (2020). Overexpression of Bone Morphogenetic Protein-1 Promotes Osteogenesis of Bone Marrow Mesenchymal Stem Cells In Vitro. Medical science monitor: international medical journal of experimental and clinical research, 26, e920122-1.

Banerjee, S., Andrew, R. J., Duff, C. J., Fisher, K., Jackson, C. D., Lawrence, C. B., ... & Hooper, N. M. (2019). Proteolysis of the low density lipoprotein receptor by bone morphogenetic protein-1 regulates cellular cholesterol uptake. Scientific reports, 9(1), 1-14.

Rosell-Garcia, T., & Rodríguez-Pascual, F. (2018). Enhancement of collagen deposition and cross-linking by coupling lysyl oxidase with bone morphogenetic protein-1 and its application in tissue engineering. Scientific reports, 8(1), 1-12.

Kallander, L. S., Washburn, D., Hilfiker, M. A., Eidam, H. S., Lawhorn, B. G., Prendergast, J., ... & Willette, B. (2018). Reverse hydroxamate inhibitors of bone morphogenetic protein 1. ACS medicinal chemistry letters, 9(7), 736-740.

Hsieh, Y. Y., Tung, S. Y., Pan, H. Y., Yen, C. W., Xu, H. W., Deng, Y. F., ... & Li, C. (2018). Upregulation of bone morphogenetic protein 1 is associated with poor prognosis of late-stage gastric Cancer patients. BMC cancer, 18(1), 1-13.

Zhang, H., Jani, P., Liang, T., Lu, Y., & Qin, C. (2017). Inactivation of bone morphogenetic protein 1 (Bmp1) and tolloid-like 1 (Tll1) in cells expressing type I collagen leads to dental and periodontal defects in mice. Journal of molecular histology, 48(2), 83-98.

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Have you used Rat Anti-BMP1 Recombinant Antibody (CBYY-0654)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Related Products

Mouse Anti-BMP1 Recombinant Antibody (CBYY-1790) (CAT#: CBMAB-2139-YY)

Rat Anti-BMP1 Recombinant Antibody (CBYY-0655) (CAT#: CBMAB-0658-YY)

Rat Anti-BMP1 Recombinant Antibody (CBYC-P027) (CAT#: CBMAB-P0109-YC)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Request bulk or custom quote Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email:

Online Inquiry